Skip to main content
Log in

Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient

  • Letter to the editor
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Ebner FH, Bornemann A, Wilhelm H, Ernemann U, Honegger J (2008) Tuberculum sellae meningioma symptomatic during pregnancy: pathophysiological considerations. Acta Neurochir (Wien) 150:189–193

    Article  CAS  Google Scholar 

  2. Pravdenkova S, Al-Mefty O, Sawyer J, Husain M (2006) Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 105:163–173

    Article  CAS  PubMed  Google Scholar 

  3. Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M (2007) Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 110:471–476

    Article  PubMed  Google Scholar 

  4. Gazzeri R, Galarza M, Gazzeri G (2007) Growth of a meningioma in a transsexual patient after estrogen–progestin therapy. N Engl J Med 357:2411–2412

    Article  CAS  PubMed  Google Scholar 

  5. Gonçalves AM, Page P, Domigo V, Méder JF, Oppenheim C (2010) Abrupt regression of a meningioma after discontinuation of cyproterone treatment. AJNR Am J Neuroradiol. doi:10.3174/ajnr.A1978

    Google Scholar 

Download references

Conflict of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sébastien Froelich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cebula, H., Pham, T.Q., Boyer, P. et al. Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient. Acta Neurochir 152, 1955–1956 (2010). https://doi.org/10.1007/s00701-010-0787-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-010-0787-2

Keywords

Navigation